MEDICLIN Aktiengesellschaft (FRA:MED)

FRA:MED Statistics

Total Valuation

FRA:MED has a market cap or net worth of EUR 168.15 million. The enterprise value is 523.82 million.

Market Cap	168.15M
Enterprise Value	523.82M

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

Current Share Class	47.50M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+3.98%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	36.92%
Float	11.44M

Valuation Ratios

The trailing PE ratio is 4.95.

PE Ratio	4.95
Forward PE	n/a
PS Ratio	0.22
PB Ratio	0.72
P/TBV Ratio	0.80
P/FCF Ratio	3.35
P/OCF Ratio	1.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.66, with an EV/FCF ratio of 10.44.

EV / Earnings	15.43
EV / Sales	0.67
EV / EBITDA	4.66
EV / EBIT	8.63
EV / FCF	10.44

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 1.96.

Current Ratio	1.82
Quick Ratio	1.74
Debt / Equity	1.96
Debt / EBITDA	4.05
Debt / FCF	9.08
Interest Coverage	2.82

Financial Efficiency

Return on equity (ROE) is 15.89% and return on invested capital (ROIC) is 5.57%.

Return on Equity (ROE)	15.89%
Return on Assets (ROA)	4.23%
Return on Invested Capital (ROIC)	5.57%
Return on Capital Employed (ROCE)	8.22%
Revenue Per Employee	112,148
Profits Per Employee	4,892
Employee Count	10,472
Asset Turnover	0.87
Inventory Turnover	80.57

Taxes

In the past 12 months, FRA:MED has paid 8.68 million in taxes.

Income Tax	8.68M
Effective Tax Rate	20.24%

Stock Price Statistics

The stock price has increased by +47.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+47.37%
50-Day Moving Average	3.08
200-Day Moving Average	2.93
Relative Strength Index (RSI)	61.29
Average Volume (20 Days)	410

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MED had revenue of EUR 778.42 million and earned 33.96 million in profits. Earnings per share was 0.71.

Revenue	778.42M
Gross Profit	175.82M
Operating Income	60.67M
Pretax Income	42.90M
Net Income	33.96M
EBITDA	82.54M
EBIT	60.67M
Earnings Per Share (EPS)	0.71

Balance Sheet

The company has 100.05 million in cash and 455.32 million in debt, giving a net cash position of -355.27 million.

Cash & Cash Equivalents	100.05M
Total Debt	455.32M
Net Cash	-355.27M
Net Cash Per Share	n/a
Equity (Book Value)	232.26M
Book Value Per Share	4.88
Working Capital	135.69M

Cash Flow

In the last 12 months, operating cash flow was 93.20 million and capital expenditures -43.03 million, giving a free cash flow of 50.17 million.

Operating Cash Flow	93.20M
Capital Expenditures	-43.03M
Free Cash Flow	50.17M
FCF Per Share	n/a

Margins

Gross margin is 22.59%, with operating and profit margins of 7.79% and 4.36%.

Gross Margin	22.59%
Operating Margin	7.79%
Pretax Margin	5.51%
Profit Margin	4.36%
EBITDA Margin	10.60%
EBIT Margin	7.79%
FCF Margin	6.44%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.19%.

Dividend Per Share	0.04
Dividend Yield	1.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	5.60%
Buyback Yield	n/a
Shareholder Yield	1.19%
Earnings Yield	20.19%
FCF Yield	29.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:MED has an Altman Z-Score of 1.46 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	8